ArticleFrontiers in nephrology2026

Successful use of obinutuzumab in focal segmental glomerulosclerosis with inadequate response to rituximab: a case report.

Andreia Rita Henriques et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.